Mark Montieth: Hometown boy Matt Gorski makes good with Indians
The Pirates life is for him, with the Indians’ major league affiliate in Pittsburgh, and given recent trends, that seems a realistic possibility.
The Pirates life is for him, with the Indians’ major league affiliate in Pittsburgh, and given recent trends, that seems a realistic possibility.
The CHIPS and Science Act is starting to tackle its goal of fueling domestic innovation and high-tech manufacturing in the areas of microelectronics, biotechnology, artificial intelligence and more, in Indiana and nationwide.
The Roche drug is a once-daily pill, compared to Lilly’s tirzepatide, sold under the brand names Mounjaro (for diabetes) and Zepbound (for obesity), which is a once-weekly shot.
This year’s list introduces nearly 70 new individuals, encompassing corporate executives, philanthropic leaders and notable personalities making significant contributions in Indiana.
Researchers reported Sunday that new blood tests were 91% accurate in detecting Alzheimer’s disease, far more accurate than a diagnosis from primary care doctors and specialists.
One thing I can control is how I balance my consumption of positive and negative information and choose to approach life as a result.
New Harmony Project isn’t taking a timid approach to its new event, PlayFest Indy. Jenni Werner, New Harmony Project’s executive artistic director since 2023, said she’s hopeful that public readings of eight new plays in mid-September plant a seed for Indianapolis to become a prominent place where works are developed. The city already has a […]
The five-year-old, clinical-stage drugmaker has already raised more than $213 million to develop therapeutics to treat rare endocrine disorders, a huge amount for a startup.
Purdue and Notre Dame will meet on a football field for the 126th time on Sept. 14, and while every sporting event presents the possibility of a life-changing experience, it’s unlikely anything as momentous as what happened 47 years ago will occur.
The five-year-old company is developing treatments for endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity. Its positive reception on Wall Street was seen as an extension of the general enthusiasm for obesity treatments.
Last month, a federal agency determined “with moderate confidence” that there is a link between higher levels of fluoride exposure and lower IQ in kids.
The the Swiss drugmaker will face off in the obesity area with leaders Novo Nordisk A/S and Indianapolis-based Eli Lilly and Co.
In response, an Indianapolis medical practice is trying to train more early-career physicians in the field of hematology to reverse the trend of dwindling numbers of physicians entering the field.
The Media Arts and Science Research Learning Arcade, or MARLA, at Indiana University Indianapolis has an ever-growing collection of some 550 vintage video games and 20 gaming consoles.
The provider of heat transfer, separation and fluid handling products announced that it has begun construction of a 324,000-square-foot facility in the County Line Commerce industrial park.
The key contests are playing out in unexpected corners of the country after what has been one of the most chaotic congressional sessions in modern times. In the end, just a handful of seats, or as little as one, could tip the balance in either chamber.
Republicans seized control of the U.S. Senate late Tuesday after flipping Democratic held seats, holding onto GOP incumbents and wresting away the majority for the first time in four years.
Preparing the Indiana workforce, increasing direct foreign investment and developing a future-focused energy plan are among the issues the new governor should tackle.
The Nature Conservancy supports policies that strengthen our resources through renewable energy, but we’re not alone in this quest. Hoosiers agree, and so do the corporations that have found our state to be attractive for business purposes.
Vivek Ramaswamy owns about $670 million in shares of Roivant Sciences, which is pursuing studies for three drugs that could land before the FDA during Donald Trump’s second term.